Recently, intranasal insulin administration was proven to activate the IRS-1-PI3K-AKT-GSK3β insulin signaling pathway and restored cognitive function in streptozotocin-induced AD mice by reversing insulin resistance [90]. This evidence concerns the gene INS and Alzheimer disease.